Asher Biotherapeutics, Inc.
Registry sponsor category
Industry
- Other names
- Asher Biotherapeutics, Inc.
- Company name
- Asher Biotherapeutics, Inc.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (3)
- A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
- A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors